The CD44 receptor of lymphoma cells: Structure-function relationships and mechanism of activation

Cell Adhesion and Communication

Volumn 7, Issue 4, 2000, Pages 331-347

  Rochman, Mark ^a   Moll, Jürgen ^b   Herrlich, Peter ^b   Wallach, Shulamit Batya ^a   Nedvetzki, Shlomo ^a   Sionov, Ronit Vogt ^a   Gölan, Itshak ^a   Ish Shalom, Dvorah ^a   Naor, David ^a  

^a HEBREW UNIVERSITY   (Israel)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Adhesion molecules; CD44; Glycosylation; Hyaluronic acid; Lymphoma; Sialic acid

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; SIALIC ACID; TUNICAMYCIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; LYMPHOMA CELL; MICROFILAMENT; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0033973369     PISSN: 10615385     EISSN: None     Source Type: Journal    
DOI: 10.3109/15419060009015004     Document Type: Article

References (59)

1. Bartolazzi, A., Jackson, D.G., Bennett, K.L., Aruffo, A., Dickinson, R., Shields, J., Whittle, N. and Stamenkovic, I. (1995). Regulation of growth and dissemination of a human lyraphoma by CD44 splice variants. J. Cell Sci., 108, 1723-1733.
2. Bennett, K.L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D.G., Spring, F. and Aruffo, A. (1995). Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol., 131, 1623-1633.
3. Bourguignon, L.Y.W., Lokeshwar, V.B., Chen, X. and Kerrick, W.G.L. (1993). Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J. Immunol., 151, 6634-6644.
4. Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159.
5. Coll, M.J., Serratosa, J., Bachs, O., Gahmberg, C.G. and Enrich, C. (1986). Calmodulin may decrease cell surface sialic acid and be involved in the expression of fibronectin during liver regeneration. FEBS Lett., 208, 418-422.
6. Cummings, R.D. (1992). Synthesis of asparagine-linked oligosaccharides: pathways, genetics, and metabolic regulation. In: H.J. Allen and E.C. Kisailus (Eds.), Glycocconjugates, Composition, Structure and function, pp. 333-360, Marcel Dekker, Inc., New York.
7. de Beider, A.N. and Wik, K.O. (1975). Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res., 44, 251-257.
8. Edidin, M. and Wei, T.Y. (1977). Diffusion rates of cell surface antigens of mouse-human heterokaryons. I. Analysis of the population. J. Cell Biol., 75, 475-482.
9. Edidin, M. (1992). Patches, posts and fences: proteins and plasma membrane domains. Trends in Cell Biol., 2, 376-380.
10. Galluzo, E., Albi, N., Fiorucci, S., Merigiola, C., Ruggeri, L., Tosti, A., Grossi, C.E. and Velardi, A. (1995). Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur. J. Immunol., 25, 2932-2939.
11. Geppert, T.D. and Lipsky, P.E. (1991). Association of various T cell-surface molecules with the cytoskeleton. J. Immunol., 146, 3298-3305.
12. He, Q., Lesley, J., Hyman, R., Ishihara, K. and Kincade, P.W. (1992). Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol., 119, 1711-1719.
13. Heron, D.S., Shinitzky, M., Hershkowitz, M. and Samuel, D. (1980). Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. USA, 77, 7463-7467.
14. Hyman, R., Lesley, J. and Schulte, R. (1991). Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics, 33, 392-395.
15. Isacke, C.M. (1994). The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci., 107, 2353-2359.
16. Jackson, D.G., Bell, J.I., Dickinson, R., Timans, J., Shields, J. and Whittle, N. (1995). Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol., 128, 673-685.
17. Kalomiris, E.L. and Bourguignon, L.Y.W. (1989). Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-Ankyrin binding. J. Biol. Chem., 264, 8113-8119.
18. Katoh, S., Zheng, Z., Oritani, K., Shimozato, T. and Kincade, P.W. (1995) Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med., 182, 419-429.
19. Lee, T.H., Wisniewski, H.G. and Vilcek, J. (1992). A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell. Biol., 116, 545-557.
20. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R. and Kincade, P.W. (1992). Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med., 175, 257-266.
21. Lesley, J., Hyman, R. and Kincade, P.W. (1993a). CD44 and its interaction with extracellular matrix. Adv. Immunol., 54, 271-335.
22. Lesley, J., Kincade, P.W. and Hyman, R. (1993b). Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol., 23, 1902-1909.
23. Lesley, J., English, N., Perschl, A., Gregoroff, J. and Hyman, R. (1995). Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med., 182, 431-437.
24. Liao, H.-X., Levesque, M.C., Patton, K., Bergamo, B., Jones, D., Moody, M.A., Telen, M.J. and Haynes, B.F. (1993). Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol., 151, 6490-6499.
25. Liu, D. and Sy, M.-S. (1996). A cystein residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med., 183, 1987-1994.
26. Lokeshwar, V.B., Fregien, N. and Bourguignon, L.Y.W. (1994). Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol., 126, 1099-1109.
27. Lugasi, H., Hajos, S., Murphy, J.R., Strom, T.B., Nichols, J., Penarroja, C. and Naor, D. (1990). Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor - a model for human T-cell malignancies expressing IL-2 receptor. Int. J. Cancer, 45, 163-167.
28. McLean, I.W. and Nakane, P.K. (1974). Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J. Histochem. Cytochem., 22, 1077-1083.
29. Miyake, K., Medina, K.L., Hayashi, S.-I., Ono, S., Hamaoka, T. and Kincade, P.W. (1990). Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med., 171, 477-488.
30. Murakami, S., Shimabukuro, Y., Miki, Y., Saho, T., Hino, E., Kasai, D., Nozaki, T., Kusumoto, Y. and Okada, H. (1994). Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J. Immunol., 152, 467-477.
31. Nabi, Z.F., Zucker-Franklin, D. and Baten, A. (1989). Phorbol ester-induced loss of membrane sialic acid: implications for tumor cytolysis by natural killer cells. J. Leukoc. Biol., 45, 183-188.
32. Nakano, T., Matsui, T. and Ota, T. (1996). Benzyl-alpha-GaINAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16B16 melanoma cells. Anticancer Res., 16, 3577-3584.
33. Naor, D., Vogt Sionov, R. and Ish-Shalom, D. (1997). CD44: structure, function, and association with the malignant process. Adv. Cancer Res., 71, 241-319.
34. Nicolson, G.L., Lacorbiere, M. and Eckhart, W. (1975). Qualitative and quantitative interactions of lectins with untreated and neuraminidase-treated normal, wild-type, and temperature-sensitive polyoma-transformed fibroblasts. Biochemistry, 14, 172-179.
35. Ohyama, Y., Kasai, K., Nomoto, H. and Inoue, Y. (1985). Frontal affinity chromatography of ovalbumin glycoasparagines on a concanavalin A-sepharose column. J. Biol. Chem., 260, 6882-6887.
36. Peach, R.J., Hollenbaugh, D., Stamenkovic, I. and Aruffo, A. (1993). Identification of hyaluronic acid binding sites m the extracellular domain of CD44. J. Cell Biol., 122, 257-264.
37. Perschl, A., Lesley, J., English, N., Trowbridge, I. and Hyman, R. (1995). Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol., 25, 495-501.
38. Pure, E., Camp, R.L., Peritt, D., Panettieri Jr. R.A., Lazaar, A.L. and Nayak, S. (1995). Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med., 181, 55-62.
39. Ruggiero, R.A., Bustuoabad, O.D., Bonfil, R.D., Meiss, R.P. and Pasqualini, C.D. (1985). "Concomitant immunity" in murine tumours of non-detectable immunogenicity. Brit. J. Cmcer, 51, 37-48.
40. Scott, J.E. (1961). The precipitation of polyanions by long-chain aliphatic ammonium salts. Biochem. J., 81, 418-424.
41. Sellers, J.R., Cuda, G., Wang, F. and Homsher, E. (1993). Myosin-specific adaptations of the motility assay. Methods Cell Biol., 39, 23-49.
42. Skelton, T.P., Zeng, C., Nocks, A. and Stamenkovic, I. (1998). Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol., 140, 431-446.
43. Sleeman, J.P., Arming, S., Moll, J.F., Hekele, A., Rudy, W., Sherman, L.S., Kreil, G., Ponta, H. and Herrich, P. (1996). Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res., 56, 3134-3141.
44. Sleeman, J.P., Moll, J., Kondo, K., Ponta, H. and Herrlich, P. (1997). Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem., 272, 31 837-31 844.
45. Springer, T. A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
46. Stamenkovic, I., Aruffo, A., Amiot, M. and Seed, B. (1991). The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10, 343-348.
47. Sy, M.S., Guo, Y.-J. and Stamenkovic, I. (1991). Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med., 174, 859-866.
48. Thomas, L., Byers, H.R., Vink, J. and Stamekovic, I. (1992). CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol., 118, 971-977.
49. Trowbridge, I.S., Lesley, J., Schulte, R., Hyman, R. and Trotter, J. (1982). Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed in lymphoid tissues. Immunogenetics, 15, 299-312.
50. Uff, C.R., Neame, S.J. and Isacke, C.M. (1995). Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur. J. Immunol., 25, 1883-1887.
51. van der Voort, R., Manten-Horst, E., Smit, L., Ostermann, E., Van Den Berg, F. and Pals, S.T. (1995). Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biocltem. Biophys. Res. Commun., 214, 137-144.
52. van Weering, D.H.J., Baas, P.D. and Bos, J.L. (1993). A PCR-based method for the analysis of human CD44 splice products. PCR Meth. Appl., 3, 100-106.
53. + lymphoma cells in lymphoid organs. Int. J. Cancer, 71, 462-469.
54. Vogt Sionov, R. and Naor, D. (1998). Calcium- and calmodulin-dependent PMA-activation of CD44 adhesion molecule: Cell Adhesion Comm., 6, 503-523.
55. Yamada, K.M. and Miyamoto, S. (1995). Integrin transmembrane signaling and cytoskeletal control. Curr. Opin. Cell Biol., 7, 681-689.
56. Zahalka, M.A., Okon, E. and Naor, D. (1993). Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18). J. Immunol., 150, 4466-4477.
57. Zahalka, M.A., Okon, E., Gosslar, U., Holzmann, B. and Naor, D. (1995). Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol. 154, 5345-5355.
58. Zheng, Z., Cummings, R.D., Pummill, P.E. and Kincade, P.W. (1997). Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells. J. Clin. Invest., 100, 1217-1229.
59. Ziomek, C.A., Schulman, S. and Edidin, M. (1980). Redistribution of membrane proteins in isolated mouse intestinal epithelial cells. J. Cell Biol., 86, 849-857.